Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study - Collins, P; Faradji, A; Morfini, M (J Thromb Haemost, 2010)